Helicobacter pylori eradication may induce de novo, but transient and mild, reflux esophagitis

Prospective endoscopic evaluation

Susumu Take, Motowo Mizuno, Kuniharu Ishiki, Yasuhiro Nagahara, Tomowo Yoshida, Kenji Yokota, Keij Oguma, Hiroyuki Okada, Kazuhide Yamamoto

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Backgrounds and Aim: The effect on reflux esophagitis of eradicating Helicobacter pylori is variable and not fully defined. We previously reported that in patients who have reflux esophagitis associated with duodenal ulcer, a significant improvement in the pre-existing reflux esophagitis occurred after H. pylori was eradicated. In the present study, we asked whether H. pylori eradication leads to de novo development of reflux esophagitis in peptic ulcer patients. Methods: Prospective post-eradication evaluations were conducted in 1195 H. pylori-positive patients with peptic ulcer diseases who were confirmed not to have reflux esophagitis by endoscopic examination before eradication therapy. After eradication therapy, endoscopy and a urea breath test were performed yearly. Results: A total of 1187 patients were followed for up to 10.0 years (a mean of 3.6 years). Reflux esophagitis developed in 279 of 1000 patients cured of infection and in 26 of 187 patients who had persistent infection (P <0.0001, Fisher's exact test). The esophagitis was mild (Los Angeles grade A) in most patients, transient in approximately one-half, and rarely necessitated long-term medication for the condition. Cure of infection, alcohol consumption, younger age, and high body mass index were identified as significant factors for the risk of developing non-transient reflux esophagitis. Conclusions: Cure of H. pylori infection may increase the risk of developing reflux esophagitis in patients with peptic ulcer, but the esophagitis is mostly mild and transient, and long-term medication is rarely required. Thus, H. pylori eradication therapy need not be withheld for fear of provoking reflux esophagitis.

Original languageEnglish
Pages (from-to)107-113
Number of pages7
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume24
Issue number1
DOIs
Publication statusPublished - 2009

Fingerprint

Peptic Esophagitis
Helicobacter pylori
Peptic Ulcer
Infection
Breath Tests
Los Angeles
Esophagitis
Helicobacter Infections
Duodenal Ulcer
Alcohol Drinking
Endoscopy
Fear
Urea
Body Mass Index
Therapeutics

Keywords

  • Eradication therapy
  • Gastroesophageal reflux disease
  • Helicobacter pylori
  • Peptic ulcer
  • Reflux esophagitis

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Helicobacter pylori eradication may induce de novo, but transient and mild, reflux esophagitis : Prospective endoscopic evaluation. / Take, Susumu; Mizuno, Motowo; Ishiki, Kuniharu; Nagahara, Yasuhiro; Yoshida, Tomowo; Yokota, Kenji; Oguma, Keij; Okada, Hiroyuki; Yamamoto, Kazuhide.

In: Journal of Gastroenterology and Hepatology (Australia), Vol. 24, No. 1, 2009, p. 107-113.

Research output: Contribution to journalArticle

Take, Susumu ; Mizuno, Motowo ; Ishiki, Kuniharu ; Nagahara, Yasuhiro ; Yoshida, Tomowo ; Yokota, Kenji ; Oguma, Keij ; Okada, Hiroyuki ; Yamamoto, Kazuhide. / Helicobacter pylori eradication may induce de novo, but transient and mild, reflux esophagitis : Prospective endoscopic evaluation. In: Journal of Gastroenterology and Hepatology (Australia). 2009 ; Vol. 24, No. 1. pp. 107-113.
@article{79624863c1d849d5a8a7e48485fb1f8e,
title = "Helicobacter pylori eradication may induce de novo, but transient and mild, reflux esophagitis: Prospective endoscopic evaluation",
abstract = "Backgrounds and Aim: The effect on reflux esophagitis of eradicating Helicobacter pylori is variable and not fully defined. We previously reported that in patients who have reflux esophagitis associated with duodenal ulcer, a significant improvement in the pre-existing reflux esophagitis occurred after H. pylori was eradicated. In the present study, we asked whether H. pylori eradication leads to de novo development of reflux esophagitis in peptic ulcer patients. Methods: Prospective post-eradication evaluations were conducted in 1195 H. pylori-positive patients with peptic ulcer diseases who were confirmed not to have reflux esophagitis by endoscopic examination before eradication therapy. After eradication therapy, endoscopy and a urea breath test were performed yearly. Results: A total of 1187 patients were followed for up to 10.0 years (a mean of 3.6 years). Reflux esophagitis developed in 279 of 1000 patients cured of infection and in 26 of 187 patients who had persistent infection (P <0.0001, Fisher's exact test). The esophagitis was mild (Los Angeles grade A) in most patients, transient in approximately one-half, and rarely necessitated long-term medication for the condition. Cure of infection, alcohol consumption, younger age, and high body mass index were identified as significant factors for the risk of developing non-transient reflux esophagitis. Conclusions: Cure of H. pylori infection may increase the risk of developing reflux esophagitis in patients with peptic ulcer, but the esophagitis is mostly mild and transient, and long-term medication is rarely required. Thus, H. pylori eradication therapy need not be withheld for fear of provoking reflux esophagitis.",
keywords = "Eradication therapy, Gastroesophageal reflux disease, Helicobacter pylori, Peptic ulcer, Reflux esophagitis",
author = "Susumu Take and Motowo Mizuno and Kuniharu Ishiki and Yasuhiro Nagahara and Tomowo Yoshida and Kenji Yokota and Keij Oguma and Hiroyuki Okada and Kazuhide Yamamoto",
year = "2009",
doi = "10.1111/j.1440-1746.2008.05606.x",
language = "English",
volume = "24",
pages = "107--113",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Helicobacter pylori eradication may induce de novo, but transient and mild, reflux esophagitis

T2 - Prospective endoscopic evaluation

AU - Take, Susumu

AU - Mizuno, Motowo

AU - Ishiki, Kuniharu

AU - Nagahara, Yasuhiro

AU - Yoshida, Tomowo

AU - Yokota, Kenji

AU - Oguma, Keij

AU - Okada, Hiroyuki

AU - Yamamoto, Kazuhide

PY - 2009

Y1 - 2009

N2 - Backgrounds and Aim: The effect on reflux esophagitis of eradicating Helicobacter pylori is variable and not fully defined. We previously reported that in patients who have reflux esophagitis associated with duodenal ulcer, a significant improvement in the pre-existing reflux esophagitis occurred after H. pylori was eradicated. In the present study, we asked whether H. pylori eradication leads to de novo development of reflux esophagitis in peptic ulcer patients. Methods: Prospective post-eradication evaluations were conducted in 1195 H. pylori-positive patients with peptic ulcer diseases who were confirmed not to have reflux esophagitis by endoscopic examination before eradication therapy. After eradication therapy, endoscopy and a urea breath test were performed yearly. Results: A total of 1187 patients were followed for up to 10.0 years (a mean of 3.6 years). Reflux esophagitis developed in 279 of 1000 patients cured of infection and in 26 of 187 patients who had persistent infection (P <0.0001, Fisher's exact test). The esophagitis was mild (Los Angeles grade A) in most patients, transient in approximately one-half, and rarely necessitated long-term medication for the condition. Cure of infection, alcohol consumption, younger age, and high body mass index were identified as significant factors for the risk of developing non-transient reflux esophagitis. Conclusions: Cure of H. pylori infection may increase the risk of developing reflux esophagitis in patients with peptic ulcer, but the esophagitis is mostly mild and transient, and long-term medication is rarely required. Thus, H. pylori eradication therapy need not be withheld for fear of provoking reflux esophagitis.

AB - Backgrounds and Aim: The effect on reflux esophagitis of eradicating Helicobacter pylori is variable and not fully defined. We previously reported that in patients who have reflux esophagitis associated with duodenal ulcer, a significant improvement in the pre-existing reflux esophagitis occurred after H. pylori was eradicated. In the present study, we asked whether H. pylori eradication leads to de novo development of reflux esophagitis in peptic ulcer patients. Methods: Prospective post-eradication evaluations were conducted in 1195 H. pylori-positive patients with peptic ulcer diseases who were confirmed not to have reflux esophagitis by endoscopic examination before eradication therapy. After eradication therapy, endoscopy and a urea breath test were performed yearly. Results: A total of 1187 patients were followed for up to 10.0 years (a mean of 3.6 years). Reflux esophagitis developed in 279 of 1000 patients cured of infection and in 26 of 187 patients who had persistent infection (P <0.0001, Fisher's exact test). The esophagitis was mild (Los Angeles grade A) in most patients, transient in approximately one-half, and rarely necessitated long-term medication for the condition. Cure of infection, alcohol consumption, younger age, and high body mass index were identified as significant factors for the risk of developing non-transient reflux esophagitis. Conclusions: Cure of H. pylori infection may increase the risk of developing reflux esophagitis in patients with peptic ulcer, but the esophagitis is mostly mild and transient, and long-term medication is rarely required. Thus, H. pylori eradication therapy need not be withheld for fear of provoking reflux esophagitis.

KW - Eradication therapy

KW - Gastroesophageal reflux disease

KW - Helicobacter pylori

KW - Peptic ulcer

KW - Reflux esophagitis

UR - http://www.scopus.com/inward/record.url?scp=58549112390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58549112390&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1746.2008.05606.x

DO - 10.1111/j.1440-1746.2008.05606.x

M3 - Article

VL - 24

SP - 107

EP - 113

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - 1

ER -